Home / Business and Economy / Promoter Sales Spark Institutional Buying Frenzy
Promoter Sales Spark Institutional Buying Frenzy
17 Sep
Summary
- Promoters sold stakes in Jamna Auto, Gland Pharma, Granules India.
- Institutional investors bought shares after strong quarterly results.
- Companies are shifting to higher-value products and markets.
In September 2026, promoter stake sales in Jamna Auto Industries, Gland Pharma, and Granules India garnered investor attention. These transactions involved notable institutional buyers like DSP Mutual Fund and Kotak Mahindra Mutual Fund, coinciding with strong quarterly results for all three companies.
Jamna Auto is diversifying beyond its reliance on the commercial vehicle OEM cycle by expanding exports, aftermarket services, and higher-value suspension products. The company aims for significant revenue growth by FY30, with new markets and exports projected to contribute 40% of revenue.
Gland Pharma is strategically moving into high-entry barrier Contract Development and Manufacturing Organization (CDMO) opportunities, which already represent nearly 50% of its sales. Future growth is anticipated from supplying oncology and non-oncology injectable products starting in CY2029.
Granules India is strengthening its complex generics business, which now constitutes 50% of its finished-dosage revenue. The company is also developing its peptide CDMO business, targeting substantial revenue and margin growth within three years. Institutional investors appear to be backing the long-term earnings improvement and business quality in these companies.
